Tiago Fauth
Stock Analyst at Wells Fargo
(0)
# 4760
Out of 5,266 analysts
155
Total ratings
31.73%
Success rate
-20.23%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Amicus Therapeutics | Maintains: Overweight | 18 17 | 9.23 | 84.18% | 1 | Feb 20, 2025 | |
Insmed | Maintains: Overweight | 85 107 | 80.51 | 32.9% | 3 | Feb 19, 2025 | |
Pliant Therapeutics | Downgrades: Equal-Weight | 41 4 | 3.03 | 32.01% | 1 | Feb 10, 2025 | |
Tectonic Therapeutic | Maintains: Overweight | 79 112 | 29.59 | 278.51% | 3 | Jan 31, 2025 | |
Inozyme Pharma | Maintains: Overweight | 14 11 | 1.27 | 766.14% | 2 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 64 74 | 67.56 | 9.53% | 3 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 75 88 | 43.25 | 103.47% | 7 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 8 | 2.67 | 199.63% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 9 | 5.74 | 56.79% | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 88 111 | 10.96 | 912.77% | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 56 68 | 50.86 | 33.7% | 1 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 11 22 | 11.14 | 97.49% | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 75 | 54.29 | 38.15% | 1 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 350 380 | 361.31 | 5.17% | 4 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 207 233 | 250.5 | -6.99% | 4 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 35 2 | 2.35 | -14.89% | 2 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 63 62 | 1.62 | 3727.16% | 5 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 89 | 153.11 | -41.87% | 16 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 51 | 16.34 | 212.12% | 3 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 120 | 68.33 | 75.62% | 7 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 120 | 2.46 | 4778.05% | 6 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Underperform | 4 | 21.01 | -80.96% | 4 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 22 17 | n/a | n/a | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 14 | 4.87 | 187.47% | 4 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 4 | 0.43 | 830.23% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 26 | 8.24 | 215.53% | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 34 28 | 3.04 | 821.05% | 7 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 70 81 | 27.53 | 194.22% | 11 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 139 200 | n/a | n/a | 5 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Underperform | 1 | n/a | n/a | 3 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 8 | 0.41 | 1851.22% | 5 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 14 | 1.27 | 1002.36% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 38 34 | 1.12 | 2935.71% | 2 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 150 | 4.58 | 3175.11% | 2 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 29 | 36.76 | -21.11% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 13 | 3.67 | 254.22% | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 13 | 1.91 | 580.63% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 20 | n/a | n/a | 3 | Sep 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 3 2 | 1.82 | 9.89% | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 297 340 | 647 | -47.45% | 3 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 18 | n/a | n/a | 2 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 102 98 | n/a | n/a | 1 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 265 259 | 304.28 | -14.88% | 1 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 60 42 | n/a | n/a | 5 | Nov 10, 2020 |